Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
Clinical trial NCT00362570 · COMPLETED
Trial details
- NCT number
- NCT00362570
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2007-04-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.